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Abstract 
An antibiotic delivery system has been developed 
using ciprotloxacin (CIPRO) encapsulated within sonicated 
unilamellar vesicles (SUV) of different lipid compositions 
composed of dipalmitoylphospatidylcholine (DPPC), L-a-
phosphatidylcholine (PC), phosphatidylethanolamine (PEA) 
and cholesterol (CHOL). The interaction of SUV (i.e. 
liposomes) with Pseudomonas aeruginosa (Tl 2977) cells was 
studied and the effect of the liposome encapsulated antibiotic 
was tested. Encapsulation of CIPRO apparently increased the 
amount of antibiotic resident in the vicinity of bacteria in 
aqueous solution at neutral pH. 
Electrophoretic mobility measurements showed that P. 
aeruginosa cells were negatively charged. The zeta potential 
of P. ae rug inosa was -11.4 ± 2.9 m V in phosphate buffered 
saline at pH 7 .0, and the corresponding surface charge density 
was -14.7 ± 3.9 mC/m2. DPPC liposomes and PC liposomes 
had mean diameters of 103 ± 35 nm and 80 ± 25nm, 
respectively. They were electrically neutral or had a small 
positive charge of +S.0 ± 3.0 mC/m2 when prepared with 
PC:CHOL:PEA=S: 1: 1. The interaction and attachment of 
neutral or positively charged SUV to negatively charged 
bacterial cells was studied in an effort to increase the 
residency of the liposomes and CIPRO, in the vicinity of the 
bacterial cells. 
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Introduction 
Encapsulation of antibiotics into phospholipid vesicles 
has several therapeutic advantages [2-8], which include an 
enhanced drug action and increased drug stability. It has been 
reported frequently [6 , l 6-l 8J that liposome encapsulated 
antibiotics arc more effective than antibiotics in solution in 
the elimination of infection. The encapsulation of antibiotics 
in liposomcs also protects the drug from hydrolysis and 
reduces drug toxicity [7] . Some liposome encapsulated drugs 
are currently being evaluated for use in human bacterial 
infections [2] . 
In this communication, as a first objective, we studied 
the encapsulation of CIPRO in sonicated unilamellar vesicles 
(SUV). CIPRO is a fluoroquinolone with substantial 
antimicrobial activity against gram-negative and gram-positive 
bacteria. Among five new quinolones, CIPRO was reported 
[ 4] as most active against S l P. aeruginosa strains. Minimum 
inhibitory concentration (MIC) was determined to be in the 
range of0.12S-l.0 mg/I against planktonic P. aeruginosa cells 
[ 4]. Much higher concentrations are required for treatment of 
P. aeruginosa biofilms [l]. The use of increased doses of 
CIPRO is limited by toxicity considerations and by the poor 
solubility of the antibiotic in solutions at neutral pH. By 
encapsulating CIPRO into liposomes, it was possible to 
expose bacteria to a higher absolute antibiotic concentration 
and use the vesicles as a depot for controlled drug release. 
The second objective of liposomal encapsulation of 
CIPRO was to prolong the residency of the drug in the 
vicinity of the bacterial cell by first - increasing unspecific 
interactions between SUV and P. aeuginosa, and second - by 
decreasing the rate of drug efflux. The unspecific , electrostatic 
interactions of liposomes with bacterial cells were 
manipulated by modifications of the lipid composition of the 
SUV. It was expected that by fonnulati ng a neutral, or 
positively charged liposome membrane, we could increase the 
electrical attraction between the negatively charged bacterial 
cells and the liposomes. It is also possible that specific head 
groups of the lipid molecules would be recognized by P. 
aeruginosa to different extents leading to specific interactions 
[ lS]. 
Abbreviations: 
DPPC - Dipalmitoylphosphatidylcholine 
PC - L-a-phosphatidylcholine Type III 
PEA - Phosphatidylethanolamine 
CHOL - Cholesterol 
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Materials and Methods 
Chemicals. L-a-phosphatidylcholine Type III (PC), 
cholesterol (CHOL), dipalmitoylphosphatidylcholine (DPPC) 
and phosphatidylethanolamine (PEA) were ~urchased from 
Sigma Chemical Company (St. Louis, MO). [ 4C]-cholesterol 
was purchased from Amersham (Ontario, Canada). CIPRO 
was from Miles Pharmaceutical (West Haven, Connecticut, 
USA). All other chemicals were of reagent grade. 
Preparation of liposomes. Liposomes were prepared 
using a modified procedure found in reference [14] from total 
of 120-125 µmoles phospholipid and cholesterol in 
methanol :chloroform (2:1) in the compositions as shown in 
Table I. Radiolabelled cholesterol [14C]-CHOL in a 
concentration of 8 x 104 dpm (spec. act. 95.0 mCi/mmol) was 
added as a tracer. Solvents were removed by evaporation at 
room temperature under a stream of nitrogen followed by 
vacuum desiccation. Dried lipid films were hydrated overnight 
with 25-100 nmole/ml (8-33 µg/ml) CIPRO in 100 mM PBS, 
pH 7.0. A control sample of liposomes was hydrated 
overnight in l ml 100 mM PBS, pH 4.0. The hydrated 
mixtures were subjected to sonication for 5 min with a 
Biosonic, (Bronwill Scientific, USA) equipped with a titanium 
tip. The liposomal suspension was centrifuged at 1,500 xg for 
10 min to eliminate the larger membranes and titanium 
particles from the sonifier probe followed by centrifugation at 
120,000 xg for 30 min. 
Determination of radioactivity. For determination of 
radioactivity the samples were mixed with a scintillation 
mixture and counted with a Beckman LS 6000IC scintillation 
counter. The reported results were the mean of two counting 
cycles and three independent experiments. Liposomal concen-
tration in the samples was determined by relative [14C]-CHOL 
radioactivity. . 
Electrophoretic mobility measurements. The mobility 
of liposomes and bacterial cell suspensions was measured 
using an automated electrokinetics analyzer, Pen Kem 3000. 
Zeta potential was determined using the Smolukowski 
equation [12] and the surface charge density (cr) of bacterial 
cells and liposomes was calculated from the Gouy-Chapman 
equation: 
where ci is the bulk molar concentration of i ion, ~ is the 
valency of the i ion, R is the gas constant, T is the absolute 
temperature and <I> is an approximation of the zeta potential 
[12]. 
Size determination. The size of liposomes was 
determined by a submicron particle size analyzer (Cauter, 
Model N4SD) and by size analysis mode of the Pen Kem 
System 3000. The mean size was determined from three 
separate liposome preparations. The mean dimension of P. 
aeruginosa cells was measured by the Pen Kem 3000. 
Drug encapsulation efficiency. The amount of 
ciprofloxacin encapsulated into liposomes was determined by 
mass balance from the total concentration, and the 
concentration in the supernatant after centrifugation of SUV 
at 130,000 xg in a Sorval ultracentrifuge OTO 65B. CIPRO 
concentration in the supernatant was determined from UV 
absorbance at 272 nm (Fig. 1). The CIPRO concentration in 
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liposomal suspensions was determined from the aqueous 
phase after phase separation. 
Susceptibility testing. The antibiotic activity was 
determined using a clinical isolate of P. aeruginosa (Tl2977) 
by the agar incorporation technique [19] containing dilutions 
of antibiotic and liposomal suspension. The inocula were 
prepared from 24 h broth cultures of the organisms adjusted 
to 106-107 colony forming units (cfu)/ml. One (or more) µJ of 
the final inoculum was applied to unsupplemented Mueller-
Hinton agar (BBL Microbiology Systems, Cockeysville, 
Maryland). The colonies were counted following 24 h 
incubation at 37°C. 
Interaction of bacieria with liposomes. To test the cell 
association of the liposomes a bacterial suspension (I 06 
cells/ml) was incubated with liposomes, which contained a 
trace amount of 14C-CHOL(l-8 x 104 dpm). Bacterial cells 
were separated from liposomes by differential centrifugation. 
Radioactivity was determined in the cell pellet and the 
supernatant. 14C-CHOL radioactivity is indicative of the 
amount of liposomes attached to the bacterial surface. 
Results and Discussion 
Lipid composition of SUV and the molar ratio of the 
lipids used for each preparation are shown in Table I. The 
lipid compositions of SUV were selected considering the 
physicochemical characteristics of the bilayer of liposomes 
[5,10] . DPPC, PC and PEA are zwitterionic phospholipids at 
neutral pH and form noncharged liposomes; PEA presents the 
most freely exposed positively charged amino group on the 
surface of the bilayer, and the SUV with a lipid composition 
including 18% PEA showed a low positive charge. DPPC was 
selected because it has a relatively high phase transition 
temperature (41.5°C) which is considered as an advantage for 
medical applications of SUV. CHOL was included in the lipid 
composition because of its influence on the rate of drug 
release [6] . The presence of cholesterol into the bilayer also 
increases the stability of liposomes [9] . 
The efficiencies of CIPRO encapsulation by our 
liposomal preparations (Table 1) were 40.2-54.3%; large lipid 
aggregates and micelles were pelleted at 1,600 rpm. 
The concentration of CIPRO in a lipid dispersion 
varied in the range of 0.2-33.0 mg/ml. Data in Table 1 
represent SUV of Lipid dispersion of 20 µmole/ml lipid and 
0.2 mg/ml CIPRO in PBS, pH 7.0. The amount of 
encapsulated CIPRO in liposomes (Table 1) with different 
lipid compositions was determined by the CIPRO adsorption 
maximum at 272 nm (Fig. la). However, it must be pointed 
out that after encapsulation into SUV, CIPRO had a broad 
absorption maximum around 272 nm, which could not be used 
for quantitative analyses (Fig. 1 b). Therefore the amount of 
encapsulated antibiotic was determined from the aqueous 
phase after phase separation of the liposomal suspension (Fig. 
le). The partitioning of CIPRO in n-octanol phosphate buffer 
phases was reported in reference [11] . 
As is seen in Table 1, the amount of CIPRO 
encapsulated into SUV remained relatively constant as a 
function of variation of the lipid composition. The maximum 
amount of CIPRO (11.76 ± 0.72 µg/µmole lipid) was found 
in DPPC liposomes. Addition of PEA into the bilayer 
decreased slightly the amount of the encapsulated antibiotic 
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Figure 1. Ultraviolet adsorption spectra of free cipro-
floxacin (a), encapsulated ciprofloxacin (b), and cipro-
floxacin extracted from liposomes (c). 
(10.16 ± 1.02 µg/µmole of lipid). The lowest amount of 
CIPRO was recorded in DPPC: CHOL liposomes (8.02 ± 1.2 
µg/µmole lipid). The differences were insignificant. However, 
the phospholipid concentration was varied in the range of 0.2-
20 µmole/ml ; at the highest concentration, the amount of 
CIPRO encapsulated reached >30 µmole/ml (data not shown). 
The value of 30 µmole/ml for encapsulated CIPRO is 
significantly higher than the concentration achieved in 
aqueous solutions at neutral pH. Thus, relatively high doses 
may be delivered via SUV. 
Liposomes having membranes with a lipid 
concentration of 6 µmole/ml were mixed with P. aeruginosa. 
cells (I 06-107 cells/ml) and incubated for different periods of 
time at room temperature. Bacterial cells were later separated 
from liposomes by ·differential centrifugation. As mentioned 
in the "Materials and Methods" section, all liposomal 
preparations, independent of their lipid composition, contained 
14C-CHOL as a tracer. Therefore, the 14C-CHOL radioactivity 
in liposomal and bacterial fractions was indicative of 
liposomal association. The liposomes that pelleted together 
with bacterial cells are considered to be attached to the cells. 
Approximately 30 per cent of the total SUV were pelleted 
together with bacterial cells after 5 min (Table 2). The 
quantity varied little for DPPC, DPPC:CHOL and PC:CHOL 
liposomes, but increased significantly for PC:CHOL:PEA 
liposomes. 
One of the reasons for the increased PC:CHOL:PEA 
liposome-bacterial association could be due to the electrostatic 
attractive force designed into the liposomal membrane by 
inclusion of PEA. Indeed, a positive ~-potential of +5.0 ± 0.3 
mV was recorded for PC:CHOL:PEA liposomes. P. 
aeruginosa bacterial cells were negatively charged with an 
electrophoretic mobility of -1.304 ± 0.622 x 10-s m2s· 1v·1, 
and had a ~-potential of -11.4 ± 2.9 m V in PBS at pH 7 .0, 
with a corresponding surface charge density of -14.7 ± 3.9 
mC/m2. These results are consistent with published reports of 
surface charge properties of microbial cells [13]. 
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Table 1. Encapsulation of ciprofloxacin into small 
unilamellar liposomes with different lipid composition . 
Lipid composition µg cipro per % recovery 
molar ratioa µmoles lipida 14C-CHOU 
DPPC 11.76 ± 0.72 40.2 ± 5.3 
DPPC:CHOL 9: 1 8.02 ± 1.20 52.7 ± 4.8 
PC:CHOL 9:1 9.07 ± 0.91 53.2 ± 4.5 
PC:CHOL:PEA 10:2:2 10.16 ± 1.02 54.3 ± 5 .0 
aResults of three independent measurements; SUV were 
sonicated in 0.2 mg/ml CIPRO with 20 µmole lipid 
dispersion. 
Table 2 . Distribution of 14C-CHOL between liposomes 
and P. aeruginosa cells after differential centrifugation. 
14C-CHOL in SUV 
composition supernatant bacteria 
(%) pellets a(%) 
DPPC 72.0 ± 4.3 26 .4 ± 5.0 
DPPC:CHOL 73.6 ± 4.0 27 .7 ± 7.5 
PC:CHOL 76.1 ± 4.8 23.9 ± 4.6 
PC:CHOL:PEA 54.2 ± 5.5 45 .8 ± 4.4 
aBacteria were incubated with 14C-CHOL liposomal sus-
pension for 5 minutes; free liposomes were separated 
from P. aeruginosa cells and the radioactivity of the 
fractions was measured. 
Bacterial cells incubated with suspensions of liposomes 
and separated from the free liposomes by differential 
centrifugation had a significantly suppressed electrophoretic 
mobility and decreased negative ~-potential (Fig. 2). 
This demonstrates that liposomal attachment to 
bacterial cells due to electrostatic attraction screened part of 
the bacterial negative surface charges. The electrostatic 
attraction phenomenon was observed with all types of SUV, 
but was more pronounced for PC:CHOL:PEA liposomes as 
expected. However, it is not excluded that PEA may serve as 
a specific adsorption site for P. aeruginosa. Prolongation of 
the incubation time of SUV with bacteria resulted in an 
increase in the amount of liposomes attached to bacterial cells 
(Table 3) for the first JO min. Subsequently, an average 
plateau value of 60% of the total liposome population was 
adherent to the bacteria. 
The clinical isolate of P. aeruginosa Tl2977 was 
tested for liposome encapsulated CIPRO susceptibility. The 
results in Table 4 show that DPPC and PC:CHOL liposomal 
encapsulated samples were equal in effectiveness as free 
CIPRO; PC:CHOL:PEA liposomes showed significantly 
increased suppression of bacterial growth. After 24 hours, the 
number of the colonies was reduced in all samples containing 
SUV especially for the PC:CHOL:PEA-containing samples 
(Table 4). 
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Figure 2. Electrophoretic mobility of bacteria (a) , 
liposomes (b), and bacteria with liposomes (c) . 
We have demonstrated that CIPRO can be readily 
encapsulated into liposomes of varying lipid composition, and 
surface electrical charge. The positively charged liposomes 
were shown to adhere to bacterial cells and improve the 
antibiotic efficacy of CIPRO. 
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Discussion with Reviewers 
R.J. Doyle: In studying the binding of the liposomes to the 
bacteria, only one concentration of liposome was used with 
only one bacterial concentration (or density). In equilibria, the 
amount of ligand bound by the receptor may be dependent on 
the concentrations of the ligands and receptors. If cooperative 
effects (positive or negative cooperativity) occur the authors 
would never have observed them by using only single 
concentrations of reactants. 
Authors: Correct. We have considered these problems 
previously and our results will be submitted for publication 
elsewhere. 
R.J. Doyle: The authors suggest that liposome(s) delivery 
methods may be useful in delivering antibiotic therapy. Yet, 
liposomes may have greater affinities for blood cells and 
proteins than for P. aeruginosa. 
Authors: This topic has been under intensive investigation 
by others. For example see Ref. 10 and 15 of the manuscript. 
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R.J. Doyle: There is a growing body of literature suggesting 
that during metabolism , many bacteria are positively charged. 
This is because the protonmoti ve force is extruding protons 
which can bind to cell wall (peptidoglycan especially). 
Dissipation of the PMF would cause the wall pH to assume 
that of the surrounding medium. Do the authors have any 
results of liposome binding to metabolically active and dead 
cells (~p = 0)? 
Authors: We have not investigated this aspect. 
H.J. Busscher: The authors mention higher antibiotic 
concentrations are required for treatment of P. aeruginosa 
biofilms. Could the authors go into this a little deeper as this 
is also the rationale for this study? 
Authors: Biofilm eliminatory concentration can be as high 
as 500 times when compared with minimum inhibitory 
concentration; see: Khoury et al. (1992) Inter. Biodeter. & 
Biodegr. 30: 187-199; Anwar et al. (1989) J. Antimicrob. 
Chemothcr. 1,24: 647-655; Nichols, W .W. et al. (1989) J. 
Gen . Microhiol. 135: 1291-1303. 
H.J. Busscher: Would hydrophobicity and/or Van der Walls 
forces not play a role in the interaction of the liposomes with 
P. aeruginosa cells? 
Authors: Definitely yes, but this was not the focus for our 
study. 
J.W. Costerton: I urge the authors to examine the efficacy 
of liposome-enclosed CIPRO on biofilms of this same 
organism. 
Authors: Thank you for the suggestion. 
R. Proctor: Table 4. These data should be more meaningful 
by presenting numbers of bacteria rather than % of control. 
If the control bacteria fell 2 orders of magnitude while the 
treated cells fell 3 orders of magnitude, then this would be 
I 0% of control. However, if the control cells grew 3 orders 
of magnitude while the expe1imental rose 2 orders of 
magnitude, then this too would be 10%, but it would be 
viewed differently. 
Authors: The concentration of bacterial cells is known as a 
number per volume, see p.2 line 15. For the liposomal 
suspension, the optical density OD and 14C-CHOL 
radioactivity were known, but not the number of SUV per 
volume. These were the reasons why we expressed the data 
as % of control. 
G. Reid: The introductory paragraph quotes references of no 
specific correlation with the system (urology) or agent 
(ciprofloxacin) in question. Is this information still relevant? 
Authors: It provides useful background information. 
G. Reid: Authors suggest that 14C-CHOL is taken up by 
bacteria. Is this true or it is just an indication of liposomal 
binding to bacteria? 
Authors: We suppose that it is indication of liposome 
binding or adherence to the bacterial surface. Additional 
experiments are needed to show that significant disintegration 
of liposomes did not occur. 
R. Nicholov, A.E. Khoury, A.W. Bruce, F. DiCosmo 
G. Reid: What viability drop occurred, if any , in the controls 
over time? 
Authors: We have expressed survival of P. aeruginosa cells 
as a % of control at 4 h" in Table 4. 
G. Reid: The data fo r 1-5 hours on Table 3 shows minor 
difference, yet that on Table 4 is vastl y different. Can this be 
explained more clearly? If adsorption if similar, why is killing 
so different? Is the killing explained by the 30 µm ol/ml 
levels? 
Authors: The data on Table 3 measured time in minutes, 
however the time in Table 4 is in hours. 
G. Reid: Is there any evidence fo r specificity in binding of 
the liposomes or did it occur by chance by being in the tubes? 
Authors: The interaction between cells and liposornes 
depends on specific design of the liposomal bilayer; 
adsorption of SUV onto bacteria cell wall is not precluded. 
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